Brokerages Set Agilent Technologies Inc (NYSE:A) PT at $86.17

Agilent Technologies Inc (NYSE:A) has been given a consensus recommendation of “Buy” by the seventeen ratings firms that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and ten have assigned a buy recommendation to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $83.92.

Several brokerages have issued reports on A. Barclays set a $330.00 price objective on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research note on Monday, July 15th. Wolfe Research began coverage on shares of Waters in a research note on Thursday, May 30th. They issued an “underperform” rating for the company. ValuEngine raised shares of Valmont Industries from a “sell” rating to a “hold” rating in a research note on Friday, July 12th. Piper Jaffray Companies set a $29.00 price objective on shares of Bausch Health Companies and gave the stock a “buy” rating in a research note on Tuesday, June 11th. Finally, Zacks Investment Research raised shares of Golub Capital BDC from a “hold” rating to a “buy” rating and set a $20.00 price target for the company in a research note on Tuesday.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. JGP Global Gestao de Recursos Ltda. acquired a new position in shares of Agilent Technologies during the 2nd quarter worth about $501,000. FDx Advisors Inc. raised its position in shares of Agilent Technologies by 6.5% during the 2nd quarter. FDx Advisors Inc. now owns 5,175 shares of the medical research company’s stock worth $386,000 after purchasing an additional 315 shares during the last quarter. Prentiss Smith & Co. Inc. raised its position in shares of Agilent Technologies by 484.9% during the 2nd quarter. Prentiss Smith & Co. Inc. now owns 58,428 shares of the medical research company’s stock worth $4,363,000 after purchasing an additional 48,438 shares during the last quarter. Bessemer Group Inc. raised its position in shares of Agilent Technologies by 2.9% during the 2nd quarter. Bessemer Group Inc. now owns 261,090 shares of the medical research company’s stock worth $19,495,000 after purchasing an additional 7,376 shares during the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt raised its position in shares of Agilent Technologies by 31.5% during the 2nd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 3,755 shares of the medical research company’s stock worth $280,000 after purchasing an additional 900 shares during the last quarter.

A traded down $1.43 on Friday, hitting $68.70. The company had a trading volume of 2,694,430 shares, compared to its average volume of 2,326,436. The firm has a market cap of $22.16 billion, a P/E ratio of 24.62, a PEG ratio of 1.95 and a beta of 1.41. Agilent Technologies has a 12-month low of $61.01 and a 12-month high of $82.27. The company has a debt-to-equity ratio of 0.35, a quick ratio of 2.82 and a current ratio of 3.41. The company’s fifty day moving average is $71.67.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Tuesday, May 14th. The medical research company reported $0.71 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.72 by ($0.01). The firm had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.27 billion. Agilent Technologies had a return on equity of 19.71% and a net margin of 22.25%. The firm’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.65 EPS. On average, sell-side analysts anticipate that Agilent Technologies will post 3.05 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 24th. Stockholders of record on Tuesday, July 2nd will be paid a dividend of $0.164 per share. This represents a $0.66 annualized dividend and a dividend yield of 0.95%. The ex-dividend date of this dividend is Monday, July 1st. Agilent Technologies’s dividend payout ratio is presently 23.66%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Featured Story: Book Value Per Share – BVPS

Analyst Recommendations for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.